This document discusses Novozymes, a $2 billion industrial biotechnology company. It summarizes Novozymes' business areas and operations. It then describes Novozymes' use of internal crowdsourcing and screening teams to generate ideas for new enzyme claims and products in under a year. Research was presented analyzing whether these groups were receptive to market needs articulated in idea posts. While the screening team was responsive, the crowd was indifferent. However, the screening team still selected an excellent idea. The document concludes by discussing implications and lessons learned for using crowdsourcing to accelerate innovation.